NuWave Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-478
| Closed | -$87K | – | 426 |
|
2021
Q3 | $87K | Sell |
478
-1,515
| -76% | -$276K | 0.1% | 209 |
|
2021
Q2 | $402K | Buy |
1,993
+641
| +47% | +$129K | 0.45% | 71 |
|
2021
Q1 | $291K | Buy |
+1,352
| New | +$291K | 0.37% | 99 |
|
2020
Q4 | – | Sell |
-23
| Closed | -$6K | – | 532 |
|
2020
Q3 | $6K | Sell |
23
-944
| -98% | -$246K | 0.01% | 356 |
|
2020
Q2 | $275K | Buy |
+967
| New | +$275K | 0.36% | 81 |
|
2020
Q1 | – | Sell |
-3,586
| Closed | -$785K | – | 409 |
|
2019
Q4 | $785K | Buy |
3,586
+3,492
| +3,715% | +$764K | 0.77% | 29 |
|
2019
Q3 | $16K | Sell |
94
-128
| -58% | -$21.8K | 0.02% | 334 |
|
2019
Q2 | $41K | Sell |
222
-567
| -72% | -$105K | 0.04% | 239 |
|
2019
Q1 | $146K | Buy |
+789
| New | +$146K | 0.17% | 163 |
|
2018
Q4 | – | Sell |
-104
| Closed | -$20K | – | 429 |
|
2018
Q3 | $20K | Buy |
104
+100
| +2,500% | +$19.2K | 0.03% | 225 |
|
2018
Q2 | $1K | Sell |
4
-1,152
| -100% | -$288K | ﹤0.01% | 367 |
|
2018
Q1 | $184K | Buy |
1,156
+1,096
| +1,827% | +$174K | 0.29% | 112 |
|
2017
Q4 | $9K | Buy |
+60
| New | +$9K | 0.01% | 264 |
|
2014
Q3 | $148K | Sell |
1,318
-142
| -10% | -$15.9K | 0.42% | 89 |
|
2014
Q2 | $138K | Buy |
1,460
+565
| +63% | +$53.4K | 0.36% | 110 |
|
2014
Q1 | $63K | Sell |
895
-4,037
| -82% | -$284K | 0.19% | 152 |
|
2013
Q4 | $367K | Sell |
4,932
-12,159
| -71% | -$905K | 0.32% | 114 |
|
2013
Q3 | $1.3M | Buy |
17,091
+14,199
| +491% | +$1.08M | 1.18% | 21 |
|
2013
Q2 | $232K | Buy |
+2,892
| New | +$232K | 0.25% | 119 |
|